STOTIXA (TIVOZANIB HCL) CAPSULES
Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Feb 2014)
What this means for you
This application is over — abandoned 24 Feb 2014. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85636625
- Mark type
- Design + words
- Filed
- 28 May 2012
- Published for opposition
- 27 Nov 2012
- Abandoned
- 24 Feb 2014
- Attorney of record
- Timothy H. Hiebert
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, namely pharmaceutical preparations containing tivozanib hydrochloride
Owner
- AVEO Pharmaceuticals, Inc., Cambridge, MA, US
- AVEO Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 24 Feb 2014 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 24 Feb 2014 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Jul 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jul 2013 — SOU EXTENSION 1 GRANTED
- 16 Jul 2013 — SOU EXTENSION 1 FILED
- 16 Jul 2013 — SOU TEAS EXTENSION RECEIVED
- 22 Jan 2013 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Nov 2012 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Nov 2012 — PUBLISHED FOR OPPOSITION
- 07 Nov 2012 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Oct 2012 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 18 Oct 2012 — ASSIGNED TO LIE
- 03 Oct 2012 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Oct 2012 — EXAMINER'S AMENDMENT ENTERED
- 03 Oct 2012 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED